Al-Obaidi, Issraa
Krome, Anna K.
Wagner, Karl G.
Pfarr, Kenneth
Kuesel, Annette C.
Batchelor, Hannah K.
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (INTER/EDCTP/19/14338294/MiniMox/Vaillant)
Article History
Received: 24 August 2022
Accepted: 12 October 2022
First Online: 12 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: ACK managed the development of moxidectin at WHO/TDR. RS is staff of MDGH to whom WHO licensed the data on moxidectin at its disposal.